abstract |
The invention provides preparation and application of an imidazole aromatic ring compound, and particularly provides a compound shown as a formula I, wherein the definition of each group is described in the specification. The compound has TRK kinase inhibitory activity and can be used as a pharmaceutical composition for treating TRK dysfunction related diseases. |